PTAB Nixes Patent Claims For Device To Measure Blood Clots

By Adam Lidgett (June 22, 2022, 6:48 PM EDT) -- The Patent Trial and Appeal Board has found a host of claims in a patent for a device meant to measure characteristics of blood clots were invalid, finding they were obvious in light of prior patents and a research paper.

A panel of three administrative patent judges on Tuesday found 19 claims in the patent owned by C.A. Casyso GmbH were not valid, handing a win to patent challenger HemoSonics LLC. The panel said those claims were obvious over a combination of various patents and a printed publication referred to by the judges as Lang.

For one thing, the board said...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

PTAB Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!